Optimizing phage-antibiotic combinations: impact of administration order against daptomycin non-susceptible (DNS) MRSA clinical isolates

Bleick CR, Van Helden SR, Berti AD, Richa R, Lehman SM, Bayer AS, Rybak MJ. Optimizing phage-antibiotic combinations: impact of administration order against daptomycin non-susceptible (DNS) MRSA clinical isolates. Antimicrob Agents Chemother. 2025 Dec 10;69(12):e0069925. doi: 10.1128/aac.00699-25. Epub 2025 Nov 18. PMID: 41251374; PMCID: PMC12691696.


Related Posts